Abstract

Acute Promyelocytic Leukemia: Current Treatment Protocols

Acute promyelocytic leukemia is a distinct subtype of acute myelocytic leukemia. It has distinct genetic and molecular profile than other acute leukemia subtypes. Due to its distinct molecular signature, the chemotherapeutic regimens utilized bear distinct treatment protocols. Various chemotherapeutic agents used include all-trans-retinoic acid, arsenic trioxide and taxanes. Recently, immunotherapy has been implored as a possible treatment protocol but with limited success.


Author(s): Isha Talwar* and Ajay

Abstract | Full-Text | PDF

Share This Article
Awards Nomination 17+ Million Readerbase
Google Scholar citation report
Citations : 256

American Journal of Pharmacology and Pharmacotherapeutics received 256 citations as per Google Scholar report

Abstracted/Indexed in
  • Google Scholar
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • IndianScience.in
  • Jour Informatics
  • CiteSeerx
  • American Standards for Journals and Research (ASJR)
  • InfoBase Index
  • Secret Search Engine Labs
  • Euro Pub

View More »